Stay updated on Zevor-cel in Relapsed/Refractory Multiple Myeloma Clinical Trial
Sign up to get notified when there's something new on the Zevor-cel in Relapsed/Refractory Multiple Myeloma Clinical Trial page.

Latest updates to the Zevor-cel in Relapsed/Refractory Multiple Myeloma Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedAdded revision note 'Revision: v3.3.3' and removed the older 'Revision: v3.3.2' entry; the HHS Vulnerability Disclosure footer link was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check16 days agoNo Change Detected
- Check24 days agoNo Change Detected
- Check31 days agoChange DetectedRevision: v3.3.2 appears to be a minor site update compared to the previous version v3.3.1, with no apparent changes to study records or their content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check38 days agoChange DetectedA new revision entry v3.3.1 was added to the record history. The prior revision v3.2.0 was removed from the current listing.SummaryDifference0.1%

- Check45 days agoChange DetectedThe government funding-operating status notice banner was removed from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.6%

- Check59 days agoChange DetectedThe new screenshot shows a minor UI/layout revision on the Record History page with no changes to study data or status. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check88 days agoChange DetectedMajor update: page now includes a government funding status notice and indicates version 3.2.0, replacing the previous 3.1.0.SummaryDifference11%

Stay in the know with updates to Zevor-cel in Relapsed/Refractory Multiple Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Zevor-cel in Relapsed/Refractory Multiple Myeloma Clinical Trial page.